.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AH01_Celecoxib.Celecoxib .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AH01_Celecoxib.Celecoxib| name: | Celecoxib |
| ATC code: | M01AH01 | route: | oral |
| n-compartments | 2 |
Celecoxib is a selective COX-2 inhibitor nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, and acute pain. It is an approved prescription medication in many countries.
Pharmacokinetics in healthy adult volunteers after a single oral dose administration.
Dhondt, L, et al., & Antonissen, G (2017). Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus). Scientific reports 7(1) 12043–None. DOI:10.1038/s41598-017-12159-z PUBMED:https://pubmed.ncbi.nlm.nih.gov/28947805
Kim, SH, et al., & Lee, SY (2017). Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite. Archives of pharmacal research 40(3) 382–390. DOI:10.1007/s12272-016-0861-2 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27864660
Dooner, H, et al., & Smith, K (2019). Pharmacokinetics of Tramadol and Celecoxib in Japanese and Caucasian Subjects Following Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label Study. European journal of drug metabolism and pharmacokinetics 44(1) 63–75. DOI:10.1007/s13318-018-0491-9 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29956215